Related Experiment Video
Updated: Mar 31, 2026
Enrichment of Bruch's Membrane from Human Donor Eyes
Published on: November 15, 2015
Complement pathway biomarkers and age-related macular degeneration
M Gemenetzi1, A J Lotery2,3
1Royal Eye Unit, Kingston Hospital NHS Foundation Trust, Kingston Upon Thames, UK.
Inflammation and complement activation drive age-related macular degeneration (AMD) progression. Genetic profiling of AMD patients may optimize future clinical trials for targeted therapies.
Area of Science:
- Ophthalmology
- Immunology
- Genetics
Background:
- Age-related macular degeneration (AMD) pathogenesis involves local inflammation and complement system activation.
- Genetic factors are significantly associated with AMD development and progression.
Purpose of the Study:
- To explore the role of genetic profiling in stratifying patients for age-related macular degeneration (AMD) clinical trials.
- To enhance the efficiency and impact of future therapeutic interventions for AMD.
Main Methods:
- Review of existing literature on AMD pathogenesis, inflammation, complement activation, and genetic associations.
- Analysis of the potential benefits of genetic stratification in clinical trial design.
Main Results:
- Genetic variations are key indicators of AMD risk and progression.
- Patient stratification based on genetic profiles can refine trial eligibility criteria.
Conclusions:
- Genetic stratification holds promise for optimizing age-related macular degeneration (AMD) clinical trials.
- Tailoring trials to genetic profiles may lead to more meaningful endpoints, reduced sample sizes, and shorter study durations.
More Related Videos
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
09:24A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
Published on: March 10, 2023
